Ypsomed Holding Past Earnings Performance

Past criteria checks 3/6

Ypsomed Holding has been growing earnings at an average annual rate of 44.9%, while the Medical Equipment industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 8.9% per year. Ypsomed Holding's return on equity is 12%, and it has net margins of 12.1%.

Key information

44.9%

Earnings growth rate

43.5%

EPS growth rate

Medical Equipment Industry Growth11.1%
Revenue growth rate8.9%
Return on equity12.0%
Net Margin12.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings

Nov 20
We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings

Recent updates

We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings

Nov 20
We Think That There Are Some Issues For Ypsomed Holding (VTX:YPSN) Beyond Its Promising Earnings

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results

Nov 17
Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Interim Results

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Aug 13
Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Jul 31
There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital

If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Jul 03
If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise

Jun 19
Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?

Jun 10
Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results

May 25
Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

May 08
Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital

Apr 07
Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital

Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?

Mar 09
Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?

Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today

Feb 07
Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today

We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Jan 23
We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Ypsomed Holding AG's (VTX:YPSN) Popularity With Investors Is Clear

Jan 08
Ypsomed Holding AG's (VTX:YPSN) Popularity With Investors Is Clear

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Dec 23
Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Revenue & Expenses Breakdown

How Ypsomed Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SWX:YPSN Revenue, expenses and earnings (CHF Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24617741160
30 Jun 24583761120
31 Mar 24548781080
31 Dec 23529751070
30 Sep 23509721050
30 Jun 23503621040
31 Mar 23497511030
31 Dec 2249241990
30 Sep 2248631950
30 Jun 2247627920
31 Mar 2246523890
30 Sep 214276970
30 Jun 214156960
31 Mar 214046940
30 Sep 2040311870
30 Jun 2039911880
31 Mar 2039412890
31 Dec 1939012900
30 Sep 1938612900
30 Jun 1942036900
31 Mar 1945460900
31 Dec 1848372900
30 Sep 1851185890
30 Jun 1848968860
31 Mar 1846652820
31 Dec 1744250780
30 Sep 1741847750
30 Jun 1740447740
31 Mar 1739046730
31 Dec 1637745700
30 Sep 1636543670
30 Jun 1635139640
31 Mar 1633736620
31 Dec 1532631610
30 Sep 1531626600
30 Jun 1531122600
31 Mar 1530719600
31 Dec 1430019590
30 Sep 1429318580
30 Jun 1428516570
31 Mar 1427614550
31 Dec 132669550

Quality Earnings: YPSN has high quality earnings.

Growing Profit Margin: YPSN's current net profit margins (12.1%) are lower than last year (14.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: YPSN's earnings have grown significantly by 44.9% per year over the past 5 years.

Accelerating Growth: YPSN's earnings growth over the past year (2.7%) is below its 5-year average (44.9% per year).

Earnings vs Industry: YPSN earnings growth over the past year (2.7%) exceeded the Medical Equipment industry -1.6%.


Return on Equity

High ROE: YPSN's Return on Equity (12%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 19:51
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ypsomed Holding AG is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carla BänzigerBank Vontobel AG
Gaurav JainBarclays
Curtis MoilesBNP Paribas Exane